Roanna Ruiz
Stock Analyst at Leerink Partners
(0.90)
# 4,079
Out of 5,162 analysts
462
Total ratings
44.4%
Success rate
-1.2%
Average return
Main Sectors:
Stocks Rated by Roanna Ruiz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KARD Kardigan | Rated: Buy | $37 → $36 | $12.52 | +187.54% | 2 | Nov 16, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 → $11 | $3.71 | +196.90% | 25 | Nov 5, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $725 | $559.10 | +29.67% | 30 | Nov 5, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $17 | $8.87 | +91.66% | 36 | Nov 5, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $15 → $16 | $5.08 | +214.96% | 12 | Oct 20, 2026 | |
| MNKD MannKind | Reiterated: Buy | $7 | $3.95 | +77.22% | 2 | Sep 10, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $9 → $16 | $16.62 | -3.73% | 36 | Sep 10, 2026 | |
| SPRY ARS Pharmaceuticals | Reiterated: Buy | $28 → $15 | $3.36 | +346.43% | 28 | Sep 8, 2026 | |
| AKBA Akebia Therapeutics | Downgraded: Hold | $7 → $1 | $0.4223 | +136.80% | 7 | Aug 7, 2026 | |
| LNTH Lantheus Holdings | Downgraded: Hold | $99 → $103 | $102.10 | +0.39% | 54 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $6 | $0.801 | +649.06% | 3 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $51.46 | - | 30 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $13.72 | n/a | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $9 | $7.98 | n/a | 37 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.00 → $2.00 | $0.94 | n/a | 8 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $1.67 | n/a | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $44 | $19.51 | n/a | 27 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $3.06 | n/a | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $11.26 | n/a | 30 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $175.34 | n/a | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $4 | $3.93 | n/a | 23 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 | $1.25 | n/a | 22 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $64.98 | n/a | 6 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $0.000001 | n/a | 13 | Dec 20, 2022 |
Kardigan
Nov 16, 2026
Rated: Buy
Price Target: $37 → $36
Current: $12.52
Upside: +187.54%
Aquestive Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $3.71
Upside: +196.90%
United Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $725
Current: $559.10
Upside: +29.67%
Vir Biotechnology
Nov 5, 2026
Reiterated: Buy
Price Target: $17
Current: $8.87
Upside: +91.66%
CorMedix
Oct 20, 2026
Reiterated: Buy
Price Target: $15 → $16
Current: $5.08
Upside: +214.96%
MannKind
Sep 10, 2026
Reiterated: Buy
Price Target: $7
Current: $3.95
Upside: +77.22%
Xeris Biopharma Holdings
Sep 10, 2026
Reiterated: Buy
Price Target: $9 → $16
Current: $16.62
Upside: -3.73%
ARS Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $28 → $15
Current: $3.36
Upside: +346.43%
Akebia Therapeutics
Aug 7, 2026
Downgraded: Hold
Price Target: $7 → $1
Current: $0.4223
Upside: +136.80%
Lantheus Holdings
Aug 3, 2026
Downgraded: Hold
Price Target: $99 → $103
Current: $102.10
Upside: +0.39%
May 15, 2026
Reiterated: Buy
Price Target: $5 → $6
Current: $0.801
Upside: +649.06%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $51.46
Upside: -
Nov 18, 2025
Reiterated: Buy
Price Target: $16
Current: $13.72
Upside: n/a
Oct 1, 2025
Reiterated: Hold
Price Target: $7 → $9
Current: $7.98
Upside: n/a
Aug 25, 2025
Reiterated: Hold
Price Target: $1.00 → $2.00
Current: $0.94
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $1.67
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $107 → $44
Current: $19.51
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $10 → $11
Current: $3.06
Upside: n/a
Jul 31, 2025
Reiterated: Hold
Price Target: $10
Current: $11.26
Upside: n/a
Mar 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $175.34
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $5 → $4
Current: $3.93
Upside: n/a
May 7, 2024
Reiterated: Hold
Price Target: $25
Current: $1.25
Upside: n/a
Jan 22, 2024
Reiterated: Hold
Price Target: $23
Current: $64.98
Upside: n/a
Dec 20, 2022
Reiterated: Hold
Price Target: $80
Current: $0.000001
Upside: n/a